Method | Medical wards (a) n = 30 | Surgical wards (b) n = 27 | ICUs (c) n = 27 | P | Post-hoc (Bonferroni)a |
---|
Mean ± SD |
---|
Fluorescent marker |
Phase 1 | 39.0 ± 10.7 | 23.0 ± 13.3 | 56.5 ± 10.5 | < .001 | a > b*, c > a**, c > b*** |
Phase 2 | 74.7 ± 16.8 | 68.9 ± 21.6 | 80.4 ± 13.6 | .339 | – |
Phase 3 | 87.3 ± 8.9 | 80.4 ± 12.9 | 88.1 ± 6.7 | .196 | – |
ATP |
Phase 1 | 68.0 ± 7.2 | 57.0 ± 12.7 | 64.8 ± 17.6 | .195 | – |
Phase 2 | 89.3 ± 6.4 | 87.4 ± 11.9 | 77.0 ± 11.2 | .031 | a > c* |
Phase 3 | 88.0 ± 5.0 | 93.0 ± 6.3 | 78.5 ± 11.0 | .002 | b > c* |
ACC |
Phase 1 | 90.3 ± 6.6 | 88.9 ± 6.1 | 96.1 ± 3.9 | .027 | c > b* |
Phase 2 | 93.7 ± 4.6 | 98.1 ± 2.6 | 98.0 ± 2.6 | .015 | b > a*, c > a* |
Phase 3 | 95.3 ± 3.6 | 96.3 ± 4.5 | 95.2 ± 7.1 | .885 | – |
- NOTE. ATP ATP bioluminescence assay, ACC aerobic colony count, ICUs intensive care units, SD standard deviation
- a*P < .05, **P < .01, ***P < .001